Applied Clinical Trials-01-01-2007

Tool places sponsors in control of their patient recruitment programs with real-time data reporting

Shift in Congressional control opens door to probes into research practices & expansion of PDUFA legislation.

While not a panacea, pharmacogenomics is still a valuable trial tool that can make the recruitment process more efficient and eliminate the high costs associated with late-stage product failure.

AstraZeneca's interpretation of the EU Clinical Trial Directive: An industry perspective

System treats compliance as a single, repeatable process to ensure organizational quality

Get to know the newest ACT Editorial Advisory Board member.

Patient safety, orphan medicines featured in EU's six-year research support budget.

Safety issues come under close scrutiny at Amsterdam meeting.

Real examples from recent studies illustrate the risks associated with making such a delicate decision.

In this Web-based strategy, suppliers bid "down" prices for the privilege to sell their products and services. Is big pharma sold?

Web-based system puts sponsors running brain function clinical trials in the know